1910 Genetics vs Parallel Bio

<p>1910 Genetics is an AI-driven software platform that transforms drug discovery by combining massive multimodal data, advanced AI models, and high-throughput laboratory automation. It targets scientists, researchers, and biotech companies aiming to innovate therapeutics effectively. By leveraging its proprietary ITO™ platform and PEGASUS™ AI model, you can speed up the development of breakthrough small and large molecule drugs, including macrocyclic peptides.</p> <p>With 1910 Genetics, you get a cohesive environment that supports collaboration, molecular design, and data integration tailored for AI-enabled discovery. You can also engage in co-engineering services to build customized drug discovery modules using interactive tools such as dashboards and chatbots. This platform is designed to push innovation boundaries in biotech, helping you get drugs to market faster with more precision and efficiency.</p>

<p>Parallel Bio is a cutting-edge platform that combines immune organoids and artificial intelligence to revolutionize drug discovery. It enables you to design immunotherapies that target the human immune system directly, bypassing traditional, inefficient animal models. With this software, you can accelerate the development of drugs with higher chances of success, saving time and resources.</p> <p>This platform offers capabilities like in vitro testing on diverse human immune system replicas, predictive disease modeling, and AI-driven target discovery. Parallel Bio focuses on safer, faster, and cheaper drug development, benefiting pharmaceutical companies aiming to bring effective therapies to market while reducing reliance on animal testing.</p>